Market Cap
$13.00 B
+$127.57 M+0.99%
Thu, 28 Nov 2024 00:12:27 GMT
Summary:
Neurocrine Biosciences market capitalization is currently $13.00 billion, with a rise of +$127.57 million (+0.99%) during the most recent trading day. Over the past year, it has increased by +$1.66 billion (+14.66%). NBIX market cap is now -16.93% below its all-time high of $15.65 billion.NBIX Market Cap Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
NBIX Market Cap Performance
| PeriodPeriod | Market capMarket cap | PricePrice | Shares outstandingShares outstanding | TTM Dividend per shareTTM Dividend per share |
|---|---|---|---|---|
| todaytoday | +1.0% | +1.0% | +0.1% | - |
| 1 m1 month | +10.6% | +10.6% | - | - |
| 3 m3 months | -15.5% | -15.7% | - | - |
| 6 m6 months | -7.7% | -8.2% | - | - |
| ytdytd | -0.7% | -3.2% | - | - |
| 1 y1 year | +14.7% | +11.3% | +3.1% | - |
| 5 y5 years | +19.9% | +9.1% | +10.0% | - |
NBIX Market Cap High & Low
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1 month | $13 B | -1.3% | $12 B | +10.7% |
| 3 m | 3 months | $15 B | -15.5% | $11 B | +16.0% |
| 6 m | 6 months | $16 B | -16.9% | $11 B | +16.0% |
| 1 y | 1 year | $16 B | -16.9% | $11 B | +18.0% |
| 3 y | 3 years | $16 B | -16.9% | $6.88 B | +89.1% |
| 5 y | 5 years | $16 B | -16.9% | $6.88 B | +89.1% |
| alltime | all time | $16 B | -16.9% | $73 M | >+9999.0% |
Neurocrine Biosciences Market Cap History
| Date | Value |
|---|---|
| 2024 | $13.00 B(-0.7%) |
| 2023 | $13.10 B(+13.6%) |
| 2022 | $11.53 B(+42.6%) |
| 2021 | $8.08 B(-9.8%) |
| 2020 | $8.96 B(-9.6%) |
| 2019 | $9.92 B(+53.0%) |
| 2018 | $6.48 B(-5.9%) |
| 2017 | $6.89 B(+104.9%) |
| 2016 | $3.36 B(-31.1%) |
| 2015 | $4.88 B(+185.7%) |
| 2014 | $1.71 B(+171.6%) |
| 2013 | $629.06 M(+26.6%) |
| 2012 | $497.02 M(+5.8%) |
| 2011 | $469.73 M(+12.0%) |
| Date | Value |
|---|---|
| 2010 | $419.30 M(+250.4%) |
| 2009 | $119.66 M(-3.1%) |
| 2008 | $123.51 M(-28.9%) |
| 2007 | $173.76 M(-56.0%) |
| 2006 | $394.98 M(-83.0%) |
| 2005 | $2.33 B(+29.3%) |
| 2004 | $1.80 B(-6.5%) |
| 2003 | $1.93 B(+37.6%) |
| 2002 | $1.40 B(-10.1%) |
| 2001 | $1.56 B(+85.7%) |
| 2000 | $838.54 M(+56.8%) |
| 1999 | $534.80 M(+310.9%) |
| 1998 | $130.15 M(-6.6%) |
| 1997 | $139.29 M(-24.2%) |
| 1996 | $183.70 M |
FAQ
- What is Neurocrine Biosciences market capitalization?
- What is the all time high market cap for Neurocrine Biosciences?
- What is NBIX market capitalization year-to-date change?
- What is Neurocrine Biosciences market cap year-on-year change?
What is Neurocrine Biosciences market capitalization?
The current market cap of NBIX is $13.00 B
What is the all time high market cap for Neurocrine Biosciences?
Neurocrine Biosciences all-time high market capitalization is $15.65 B
What is NBIX market capitalization year-to-date change?
Neurocrine Biosciences market capitalization has changed by -$95.39 M (-0.73%) since the beginning of the year
What is Neurocrine Biosciences market cap year-on-year change?
Over the past year, NBIX market capitalization has changed by +$1.66 B (+14.66%)